Where I see patients (3)
Selected research
-
Mesothelin-targeting T cell receptor fusion construct cell therapy in refractory solid tumors: phase 1/2 trial interim results.
Nature medicine
-
Single-cell and spatial multi-omics identify innate and stromal modules targeted by anti-integrin therapy in ulcerative colitis.
bioRxiv : the preprint server for biology
-
Non-viral precision T cell receptor replacement for personalized cell therapy.
Nature
Clinical trials
Pembrolizumab With or Without Axitinib for Treatment of Locally Advanced or Metastatic Clear Ce...
TIICs will be analyzed in pre- and post-pembrolizumab-based treatment tumor specimens. The proportion of participants with a >=2-fold increase (from pre- to post-treatment) in the number of TIICs will be calculated.
Recruiting
Contact me
- Request appointment
- Refer a patient
- (415) 353-2421